| Miss Tracy Lynn Davenport, CRNA | |
|
4301 W Markham St # 783, Little Rock, AR 72205-7101 | |
| (501) 686-8000 | |
| Not Available |
| Full Name | Miss Tracy Lynn Davenport |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 4301 W Markham St # 783, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053489344 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | C02646 CRNA (Arkansas) | Primary |
| Entity Name | Nurse Anesthetist Professionals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689661696 PECOS PAC ID: 5890680714 Enrollment ID: O20040219000324 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Arkansas Anesthesia Network Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831425982 PECOS PAC ID: 3577603059 Enrollment ID: O20091214000469 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Arkansas Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497023360 PECOS PAC ID: 6406023142 Enrollment ID: O20120119000835 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Gastro Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366700890 PECOS PAC ID: 3577727700 Enrollment ID: O20120619000424 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Asc Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336509819 PECOS PAC ID: 0446558134 Enrollment ID: O20160413001033 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Bp Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942736285 PECOS PAC ID: 8325319429 Enrollment ID: O20170808002928 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Premier Gastroenterology Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538663729 PECOS PAC ID: 1153685474 Enrollment ID: O20180514000249 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Clinical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518265966 PECOS PAC ID: 8325217904 Enrollment ID: O20181221000427 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Central Arkansas Gastroenterology Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639678022 PECOS PAC ID: 0840532214 Enrollment ID: O20190506000083 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Entity Name | Middle Arkansas Sedation Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447849633 PECOS PAC ID: 4486068988 Enrollment ID: O20210125001069 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Tracy Lynn Davenport, CRNA 191 Plantation Dr, Mayflower, AR 72106-8420 Ph: (501) 442-1640 | Miss Tracy Lynn Davenport, CRNA 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 |
News Archive
Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.
Golden Meditech Holdings Limited, a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March, 2011.
Now, a new study published on the preprint server bioRxiv in August 2020 shows that computational design technology can be efficiently harnessed towards this end, producing new molecules to inhibit viral entry and replication.
Offering colorectal cancer screening to poor minority women during mammography visits can effectively expand screening in this otherwise underserved population, although lack of medical insurance remains a significant barrier. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results highlight the need to find alternative funding sources for colorectal cancer screening from the government or private institutions.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.
› Verified 4 days ago
Benjamin Mizell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9601 Baptist Health Dr, Little Rock, AR 72205 Phone: 501-202-2093 Fax: 501-202-6316 | |
Dr. Ethan Taylor Lewis, DNP Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 12921 Cantrell Rd, Little Rock, AR 72223 Phone: 501-615-8296 | |
Kasia Pabian, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2018 N Garfield St, Little Rock, AR 72207 Phone: 501-614-9998 Fax: 501-325-1491 | |
John W Woodell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4200 N Rodney Parham Rd, No 203, Little Rock, AR 72212 Phone: 615-620-2320 Fax: 615-620-2323 | |
Barbara C Lenarduzzi, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 11401 Interstate 30, Little Rock, AR 72209 Phone: 501-455-7100 | |
Brent Anthony Lea, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 515, Little Rock, AR 72205 Phone: 501-686-6114 Fax: 501-686-8139 | |
Anthony L Bridges, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9601 Baptist Health Dr, Little Rock, AR 72205 Phone: 501-202-2093 Fax: 501-202-6316 |